End of the Double-Blind Randomized Control Trial?
![Pleasance et al. Nature 463, 184-190 (14 January 2010).](https://osterman.co/wp-content/uploads/2012/07/lung-cancer-genome-560x270.jpg)
The short answer is probably not – the randomized control trial is safe for now. The longer answer when it comes to exploring molecular targets in oncology we may need to rethink the double-blind randomized control trial. Since current methods Continue reading End of the Double-Blind Randomized Control Trial?